|
ZC3HAV1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.57409999995895E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.058400E-03 |
| Normal-vs-Stage2 |
7.691700E-02 |
| Normal-vs-Stage3 |
4.183800E-02 |
| Normal-vs-Stage4 |
1.316560E-01 |
| Stage1-vs-Stage2 |
3.584000E-01 |
| Stage1-vs-Stage3 |
8.253200E-01 |
| Stage1-vs-Stage4 |
9.489600E-01 |
| Stage2-vs-Stage3 |
4.544600E-01 |
| Stage2-vs-Stage4 |
3.682200E-01 |
| Stage3-vs-Stage4 |
8.199400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.87379999999826E-05 |
| Normal-vs-AfricanAmerican |
3.290500E-02 |
| Normal-vs-Asian |
7.848000E-01 |
| Caucasian-vs-AfricanAmerican |
6.236000E-01 |
| Caucasian-vs-Asian |
4.528400E-01 |
| AfricanAmerican-vs-Asian |
5.844200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.954800E-04 |
| Normal-vs-Female |
8.38550000000771E-05 |
| Male-vs-Female |
5.522000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.641900E-02 |
| Normal-vs-Extreme_Weight |
1.722020E-01 |
| Normal-vs-Obese |
2.550300E-04 |
| Normal-vs-Extreme_Obese |
4.510400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.309400E-01 |
| Normal_Weight-vs-Obese |
1.358150E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.164800E-01 |
| Extreme_Weight-vs-Obese |
1.942240E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.081200E-01 |
| Obese-vs-Extreme_Obese |
3.630000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.982200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.69950000031783E-07 |
| Normal-vs-Age(61-80Yrs) |
1.673860E-02 |
| Normal-vs-Age(81-100Yrs) |
9.695400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.362000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.936000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.986200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.961660E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.586100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.105800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.98601999999992E-05 |
| Normal-VS-Type2 PRCC |
1.186790E-01 |
| Normal-VS-KIRP CIMP |
2.933700E-02 |
| Normal-VS-Unclassified PRCC |
6.055600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.532100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.282600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.342200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.059620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.924400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.976800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.655000E-01 |
| Normal-vs-N1 |
6.797100E-03 |
| Normal-vs-N2 |
3.316000E-01 |
| N0-vs-N1 |
6.605600E-02 |
| N0-vs-N2 |
9.007400E-01 |
| N1-vs-N2 |
4.581000E-01 |
|
|
